Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2400094327Phase 4Not yet recruiting
Phase 4, randomised trial of acetaminophen in lung nodule (SPN) (2 arms), sponsored by Chengdu Jinniu District People's Hospital. Primary endpoints: Total dosage of sufentanil within 24 hours after first administration, NRS scores during exercise 24 hours after surgery and 3 more. Planned start Dec 2024; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2400094327.